This is a working overview of research compound, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-20 and is reviewed periodically as new material appears.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
== History and background == The concept of CEC gained significant attention in the early 21st century as advances in analytical techniques such as liquid chromatography - mass spectrometry (LC-MS) and gas chromatography - mass spectrometry (GC-MS) allowed for the detection of these substances at trace levels in various environmental matrices. These sophisticated tools enabled scientists to detect trace concentrations of previously overlooked chemicals in various environmental matrices including wastewater, surface water, groundwater and even drinking water samples. The increased awareness of CEC is partly due to their abundant presence in wastewater, surface water, groundwater, and drinking water, often because of urbanization, industrial activities, and the widespread use of pharmaceuticals and personal care products. The recognition of the potential risks posed by CEC has led to a growing body of research aimed at understanding their sources, fate, and effects in the environment, as well as the development of strategies for their management and removal.
===== Research ===== Research shows silkworm silk does not possess any inherent antibiotic characteristics, bio-mimicking mechanical properties, and can cause fatal respiratory allergic reactions in some people. A 2020 study found that recombinantly produced spider silk proteins self-assemble at the liquid-air interface of a standing solution, forming protein permeable, super strong and ultra flexible membranes. The unforced self-assembly creates a nanofibrilar membrane which supports cell growth. A confluent layer of human skin cells forms within three days, and would be suitable for direct delivery to a patient.
MycoTB: An extended flexible system concept for building standalone Windows software. The software allows users to build their own flexible systems on their personal computers to manage and annotate whole proteomes of MycoTB.
== Anabolic agents == Anabolic agents, or Anabolic Androgenic Steroids (AAS), are any of a group of synthetic or natural steroid hormones that builds muscle by mimicking or increasing male-producing characteristics, such as testosterones. Anabolic agents are abused by athletes in training to increase the size and strength of their muscles. However, the muscle growth only occurs when combined with rigorous physical training. Examples of anabolic agents are boldenone, clenbuterol, dehydrocholormethyl-testosterone (DHEA), nandrolone, stanozolol, testosterone, methasterone, androstenedione, norandrostenedione, methandienone, etiocholanolone, and trenbolone. Exceptions to the ban are phenylephrine and pseudoephedrine.
Sources: en.wikipedia.org
The thorax is robust and bears three pairs of legs and one pair of wings. The wings are clear and membranous, with fine veins visible, and span approximately 4 mm. They are held flat over the back when the fly is at rest. Just behind the wings are small knob-like structures called halteres, which are modified hindwings. These help the fly maintain balance and orientation in flight. The drosophila leg is composed of five leg segments: the coxa, trochanter, femur, tibia, and tarsus. They have five tarsal segments in their tarsus, ending with the fly foot which has multiple structures including the claw and adhesive structures. The pulvillus, a flexible elongated structure underneath the claw, and setae, hair-like structures that are spatula-shaped and inset the pulvilli, are the main attachment devices used by D. melanogaster, although their claws may be used for attachment onto rough surfaces. Males also have sex combs located on the first tarsal segment, which are tiny bristle-like structures on their front legs, used to attach to females during mating. Extensive images are found at FlyBase. The abdomen is segmented and tapers toward the end. It often appears striped, with alternating bands of light and dark pigmentation. In males, the abdomen is typically darker and more rounded, while females have a more pointed and striped abdomen. The black portions of the abdomen are the inspiration for the species name (melanogaster = "black-bellied"). They exhibit sexual dimorphism; females are about 2.5 mm (0.10 in) long, while males are slightly smaller.
Flory correctly identified that the chain dimension in polymer melts would have the size computed for a chain in ideal solution if excluded volume interactions were neutralized by experimenting at the theta point. Among his accomplishments are an original method for computing the probable size of a polymer in good solution, the Flory-Huggins Solution Theory, the extension of polymer physics concepts to the field of liquid crystals, and the derivation of the Flory exponent, which helps characterize the movement of polymers in solution.
=== Lung biopsy === Transthoracic lung biopsies are preferable for diagnosis of constrictive BO compared to transbronchial biopsies; regardless of the type of biopsy, a diagnosis may only be achieved by examination of multiple samples. Transthoracic biopsies are preferred over transbronchial due to the heterogeneity and distribution of the lesions. OB can be further classified into two categories: constrictive or proliferative. The constrictive pattern is demonstrated by peribronchiolar cellular infiltrates which eventually causes small airway damage and leads to subepithelial fibrosis. The bronchial muscle can eventually become fibrosed which can be identified with trichrome staining. In regards to proliferative disease, intraluminal buds called "Masson bodies" fill the lumen, which results in bronchiolar plugging. Often people with proliferative disease will show butterfly wing-like appearance under microscopy. One key determinate that can be seen on biopsy to differentiate constrictive from proliferative disease is the extent of lesions. Both lesions are localized from the small bronchi to the membranous bronchi, but in constrictive disease, the lesions are intermittent while proliferative disease has a continuous distribution.
In eukaryotes, where export of RNA is required before translation is possible, nuclear export is thought to provide additional control over gene expression. All transport in and out of the nucleus is via the nuclear pore and transport is controlled by a wide range of importin and exportin proteins. Expression of a gene coding for a protein is only possible if the messenger RNA carrying the code survives long enough to be translated. In a typical cell, an RNA molecule is only stable if specifically protected from degradation. RNA degradation has particular importance in regulation of expression in eukaryotic cells where mRNA has to travel significant distances before being translated. In eukaryotes, RNA is stabilised by certain post-transcriptional modifications, particularly the 5′ cap and poly-adenylated tail. Intentional degradation of mRNA is used not just as a defence mechanism from foreign RNA (normally from viruses) but also as a route of mRNA destabilisation. If an mRNA molecule has a complementary sequence to a small interfering RNA then it is targeted for destruction via the RNA interference pathway.
This was his best result in Miami since reaching the final in 2018. Zverev began his 2024 clay season seeded fifth at the Monte-Carlo Masters, receiving a bye into the second round and defeating Sebastian Ofner before losing to eventual champion Stefanos Tsitsipas in the third round. As the top seed at the BMW Open, Zverev received a bye into the second round and beat Jurij Rodionov before being upset by world No. 106 Cristian Garín in the quarterfinals. Seeded fourth in Madrid, Zverev reached the fourth round, beating Borna Ćorić and Denis Shapovalov before being upset by 21st seed Francisco Cerúndolo. Seeded third in Rome, Zverev won his sixth Masters title, defeating Aleksandar Vukic, Nuno Borges, Taylor Fritz, Alejandro Tabilo, and Nicolás Jarry in the final. This was his best result in Rome since winning his first Masters 1000 title at the 2017 Italian Open, and his first Masters title since 2021. At the French Open, Zverev contested Rafael Nadal's final match at the French Open, defeating the 14-time champion in straight sets to record Nadal's fourth ever defeat at the event. He went on to reach the semifinals, winning over David Goffin, Tallon Griekspoor, Holger Rune, and Alex de Minaur. He then defeated two-time finalist Casper Ruud to reach his first Major final since the 2020 US Open and his first on clay. In the deciding set of the final match, Alcaraz hit a second serve which was called out by the line judges. However, the chair umpire overruled the call, declaring the ball in.
Sources: en.wikipedia.org
=== Generic names === Gonadorelin is the generic name of the drug and its INNTooltip International Nonproprietary Name, BANTooltip British Approved Name, and JANTooltip Japanese Accepted Name, while gonadorelina is its DCITTooltip Denominazione Comune Italiana and gonadoréline is its DCFTooltip Dénomination Commune Française. The diacetate salt is known as gonadorelin acetate and this is its USANTooltip United States Adopted Name, BANMTooltip British Approved Name, and JANTooltip Japanese Accepted Name, while the hydrochloride salt is known as gonadorelin hydrochloride and this is its USANTooltip United States Adopted Name and BANMTooltip British Approved Name.
Diseases of the skin include skin infections and skin neoplasms (including skin cancer). Dermatology is the branch of medicine that deals with conditions of the skin. There are seven cervical, twelve thoracic, five lumbar, and five sacral. Certain diseases like shingles, caused by varicella-zoster infection, have pain sensations and eruptive rashes involving dermatomal distribution. Dermatomes are helpful in the diagnosis of vertebral spinal injury levels. Aside from the dermatomes, the epidermis cells are susceptible to neoplastic changes, resulting in various cancer types. The skin is also valuable for diagnosis of other conditions, since many medical signs show through the skin. Skin colour affects the visibility of these signs, a source of misdiagnosis in unaware medical personnel.
Methamphetamine is a chiral compound with two enantiomers, dextromethamphetamine and levomethamphetamine. At room temperature, the free base of methamphetamine is a clear and colorless liquid with an odor characteristic of geranium leaves. It is soluble in diethyl ether and ethanol as well as miscible with chloroform.
7 November Senior U.S. commanders in South Vietnam said that all ground combat forces could be pulled out by mid-1971. Five VC platoons numbering some 200 men attacked Saigon's District 7 but were repulsed by National Police. The PAVN attacked an ARVN riverine base 138 miles (222 km) southwest of Saigon killing 25 defenders.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.